Association between homograft tissue exposure and allosensitization prior to heart transplant in patients with congenital heart disease

Surgical repair for patients with congenital heart disease (CHD) often incorporates homograft tissue or other foreign material that can lead to allosensitization. We sought to identify the relationship between pre‐sensitization prior to heart transplant and exposure to homograft tissue in CHD patients.

[1]  G. Laufer,et al.  Donor‐specific HLA antibodies after fresh decellularized vs cryopreserved native allograft implantation , 2020, HLA.

[2]  A. Raissadati,et al.  Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients , 2019, Annals of transplantation.

[3]  J. Kobashigawa,et al.  Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[4]  C. Canter,et al.  Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children‐04 (CTOTC‐04) in pediatric heart transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  C. Canter,et al.  Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC‐04 multi‐institutional study , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  X. Jouven,et al.  Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis , 2018, PLoS medicine.

[7]  F. D. da Costa,et al.  Decellularized Allografts for Right Ventricular Outflow Tract Reconstruction in Children , 2017, World journal for pediatric & congenital heart surgery.

[8]  J. Kobashigawa,et al.  Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  B. McCrindle,et al.  Development and Impact of De Novo Anti‐HLA Antibodies in Pediatric Heart Transplant Recipients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  C. Lacelle,et al.  Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  Teresa M. Lee,et al.  Refusing Donors for HLA Sensitization Reasons Results in Increased Mortality in Pediatric Heart Transplant Candidates , 2014 .

[12]  D. Monos,et al.  Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  G. Noll,et al.  Heart Transplantation in Congenital Heart Disease: In Whom to Consider and When? , 2013, Journal of transplantation.

[14]  F. Costa,et al.  Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts. , 2012, Tissue antigens.

[15]  F. Parisi.  Heart Transplantation in Congenital Heart Disease , 2011, Current cardiology reviews.

[16]  C. Irving,et al.  Donor‐specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival , 2010, Pediatric Transplantation.

[17]  P. Reinke,et al.  Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts , 2009, Transplantation.

[18]  W. S. Ring,et al.  Antibodies Against Donor Human Leukocyte Antigens and the Outcome of Cardiac Allografts in Adults and Children , 2007, Transplantation.

[19]  S. Webber,et al.  Survival in allosensitized children after listing for cardiac transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  S. Webber,et al.  Anti‐HLA alloantibodies in pediatric solid organ transplantation , 2006, Pediatric transplantation.

[21]  S. Dunlap,et al.  The Presence of HLA-Directed Antibodies after Heart Transplantation Is Associated with Poor Allograft Outcome , 2005, Transplantation.

[22]  J. Lakey,et al.  Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  D. Hooper,et al.  Panel-reactive antibodies late after allograft implantation in children. , 2005, The Annals of thoracic surgery.

[24]  P. Terasaki,et al.  Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities , 2003, Transplantation.

[25]  L. Lambert,et al.  Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. , 2000, The Journal of thoracic and cardiovascular surgery.

[26]  L. Lambert,et al.  Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. , 1996, Circulation.